Application of extended immunotherapy in advanced clear cell renal cell carcinoma treated with first-line combination of immune-checkpoint inhibitor and tyrosine kinase inhibitor
1. 系统已在2025-03-12 14:44:20对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s11255-024-04344-7
文献链接: https://link.springer.com/10.1007/s11255-024-04344-7
其他信息:
出版社: Springer Science and Business Media LLC
作者: Qian Wang; Xingming Zhang; Qiyu Zhu; Hong Zeng; Jindong Dai; Junru Chen; Jinge Zhao; Guangxi Sun; Zhenhua Liu; Hao Zeng; Pengfei Shen
全文下载地址: https://link.springer.com/content/pdf/10.1007/s11255-024-04344-7.pdf